Global Life Sciences Solutions USA LLC
Supplier Profile
Overview
Updated August 2024
US
Incorporated Country
13
Subsidiaries
8
Tier 1 Connections
$83.85M
Prime Awards
Supplier Summary
Top Funding Offices
| Agency | Sub-Agency | Funding Office | Prime Contract Awards |
| Department of Health and Human Services | Office of Assistant Secretary for Preparedness and Response | BARDA - ASPR / DAAPPO / BARDA DCMA | $72,104,359 |
| Department of Health and Human Services | National Institutes of Health | NATIONAL INSTITUTES OF HEALTH NIAID | $4,542,626 |
| Department of Justice | Federal Bureau of Investigation | DEPT OF JUST/FEDERAL BUREAU OF INVESTIGATION | $3,408,868 |
| Department of Health and Human Services | National Institutes of Health | NIH, NIAID DEA OA OFC ACQUISITIONS | $3,185,244 |
| Department of Health and Human Services | National Institutes of Health | NIH, NCI, OD OM OA OFC ACQUISITIONS | $3,135,348 |
Top Subsidiaries
| Company Name | Country Code | Count of Contracts | Total Award Amount |
| Hyclone Laboratories, LLC | US | 218 | $3,994,217 |
| Pall Life Sciences Belgium BV | BE | 0 | $0 |
| Vanrx Pharmasystems, Inc. | CA | 0 | $0 |
| CEVEC Pharmaceuticals GmbH | DE | 0 | $0 |
| Amersham Life Sciences UK | GB | 0 | $0 |
Recent Tier 1 Suppliers
| Name | Relationship | Country | Start Date |
| Shipper Unidentified | SHIPPER | -- | -- |
| Cytiva Biotechnology (Hang Zhou) Co. Ltd. | SHIPPER | CN | -- |
| Cytiva Sweden AB | SHIPPER | SE | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
Top Contracts
| Contract ID | Entity Name | Dollars Awarded | Funding Office |
| 75A50123C00006 | Global Life Sciences Solutions USA LLC | $72,104,360 | BARDA - ASPR / DAAPPO / BARDA DCMA |
| 75N90023C00009 | Global Life Sciences Solutions USA LLC | $1,000,759 | NATIONAL INSTITUTES OF HEALTH - CC |
| 75F40122P00357 | Global Life Sciences Solutions USA LLC | $465,096 | FDA OFFICE OF ACQ GRANT SVCS |
| 75N95021C00018 | Global Life Sciences Solutions USA LLC | $460,359 | NATIONAL INSTITUTES OF HEALTH NCATS |
| HHSN273201600016C | Global Life Sciences Solutions USA LLC | $450,822 | NATIONAL INSTITUTE OF HEALTH NIEHS |
List of UEIs for Global Life Sciences Solutions USA LLC
CD8EZL9N63X6, DGVUVH2QEBS7, EGAZKJ2AGB45, ENHKAPFX1Y53, EVPXS4KTUE65, EWRNRQ3DHRE5, EZLRTNN3JWL7, F2FJSEKY5BY9, F7XJTQQJT663, FG41DG32EGC3, FSV9SVUXYCP1, G2Z5DFRAJGT5, G9ABC65PXNN3, GM49EPBCC4R7, HAM7X8LL9J15, HRF9AWPZ5HP8, HXHZH6SAK919, HYAAJG4KVBU3, JUG8BRR2M7J1, K2LJV6HCF7M4, KE6BLDLLSS61, KFNHVBCM2QL5, KU5HQBMUKB55, L291S2FT3X95, L64RUJ7LC8T9, LUUBKNAN8TK6, MK59DMGJKYP4, NAG7RNTJQ5T8, NBPFMB6U9VB9, NDWHLFL46SM5, NFRFBECQFLC8, NSVWNFP9WE46, NWU5NNT11VJ8, P55FTN1UMYZ1, PU6HHX2R11C7, QCK9HYEL4G41, SJK2ZJZLGEX4, SL9QPFFDJR34, SZ13DZFJUQQ6, T2YFU8KKZVA7, T8EKDJGJDSY7, UWFJJ3VEMK17, VN38G4R6FUB9, W6HQTMWB9Q28, XJ4FJLYHA4Z8, XQY7U3MH1RH6, YZWEFMZAUFA8, Z4DRFM3LMJB8, ZCHMXKBKMN66, ZQLBDEFJ5LR1
ABOUT SUPPLIER ANALYSIS
Ark.ai provides definitive, consolidated analyses of every vendor, subcontractor, supplier, grant awardee, non-profit, and investment organization in the national security and defense sectors. Organization profile pages provide a real-time view of the companies that impact critical government programs.
EXPLORE ADDITIONAL ANALYSES
ABOUT ARK.AI
The Ark is the only software platform purpose-built for Defense Acquisition that leverages authoritative commercial data and AI-enabled Applications designed to solve Acquisition challenges. With the Ark, analysts and decision-makers gain the ability to manage Acquisition programs proactively, allowing them to unwind the legacy complexity and effectively field modern warfighting systems that compete with China.
The Leading Defense Acquisition Software.
OUR APPLICATIONS
AI-enabled Applications within The Ark reflect standard workflows across the Defense Acquisition Process. From Science & Technology to Modernization, these Applications allow for the execution of rapid, efficient, data-informed decisions, standardized reporting, and efficient workflow management. The Ark enables your team to transform Defense Acquisition into a strategic advantage.
